Patents Assigned to NitroSystems, Inc.
  • Patent number: 6465516
    Abstract: A method for treating a subject who would benefit from increased nitric oxide production comprising administering inhibitors of Hmg-CoA-Reductase is disclosed for the treatment of diseases related to endothelial dysfunction.
    Type: Grant
    Filed: October 18, 1999
    Date of Patent: October 15, 2002
    Assignee: Nitrosystems, Inc.
    Inventor: Wayne H. Kaesemeyer
  • Patent number: 6425881
    Abstract: Vessels are treated with a mixture of L-arginine and an agent which enhances the biotransformation of L-arginine into NO. The incidents associated with restenosis are expected to be substantially reduced and prevented providing for a reduced incidence of restenosis as a result of the injury.
    Type: Grant
    Filed: April 16, 1999
    Date of Patent: July 30, 2002
    Assignee: Nitrosystems, Inc.
    Inventor: Wayne H. Kaesemeyer
  • Patent number: 6239172
    Abstract: A therapeutic mixture comprised of L-arginine and angiogenic growth factors is disclosed for the treatment of diseases related to endothelial dysfunction.
    Type: Grant
    Filed: January 7, 1999
    Date of Patent: May 29, 2001
    Assignee: NitroSystems, Inc.
    Inventor: Wayne H. Kaesemeyer